Cancer 3D Models for Metallodrug Preclinical Testing

Area of Science:

• Biomedical Research
• Drug Development
• Cancer Therapy

Background:

• Traditional 2D cell cultures and animal models in drug development face limitations including poor translational significance and ethical concerns.
• Three-dimensional (3D) cellular models offer a more accurate representation of tissue complexity and the tumor microenvironment.
• 3D models can reduce reliance on animal testing and enhance the study of cancer cell behavior and drug response.

Purpose of the Study:

• To review common types of 3D models used in cancer research.
• To discuss the application of 3D models in the preclinical evaluation of metallodrugs.
• To highlight the potential of 3D models for developing more effective and selective anti-cancer drugs.

Main Methods:

• Review of existing literature on 3D cellular models in cancer research.
• Analysis of studies utilizing 3D models for preclinical drug testing, specifically metallodrugs.
• Identification and categorization of common 3D model types and their relevance to cancer research.

Main Results:

• 3D models effectively mimic the tumor microenvironment, crucial for understanding cancer cell behavior and drug efficacy.
• Metallodrugs show therapeutic potential in cancer but their preclinical testing using 3D models is currently underexplored.
• The review consolidates information on various 3D models applicable to metallodrug screening.

Conclusions:

• 3D cellular models represent a significant advancement over traditional models in cancer research and drug development.
• Further application of 3D models in preclinical metallodrug studies is warranted to accelerate the development of novel anti-cancer therapies.
• Optimizing the use of 3D models can lead to more selective, less toxic anti-cancer drugs with reduced side effects.